✦ LIBER ✦

Granulocyte colony-stimulating factor (G-CSF) patterns of use in cancer patients receiving myelosuppressive chemotherapy

✍ Scribed by Choi, Mi Rim; Solid, Craig A.; Chia, Victoria M.; Blaes, Anne H.; Page, John H.; Barron, Richard; Arneson, Thomas J.

Book ID: 125348733
Publisher: Springer-Verlag
Year: 2014
Tongue: English
Weight: 267 KB
Volume: 22
Category: Article
ISSN: 0941-4355
DOI: 10.1007/s00520-014-2121-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

68 - Recombinant human granulocyte colon

68 - Recombinant human granulocyte colony-stimulating factor (G-SCF) in patients receiving chemotherapy for gynecologic cancer

✍ E. Cardamakis; P. Ginopoulos; L. Stathopoulos; N. Linardos; H. Mantouvalos; V. T 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 219 KB

Effects of a Formulary Change from Granu

Effects of a Formulary Change from Granulocyte Colony-Stimulating Factor to Granulocyte-Macrophage Colony-Stimulating Factor on Outcomes in Patients Treated with Myelosuppressive Chemotherapy

✍ Siu-Fun Wong; Holly O. Chan 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

Prophylactic granulocyte colony-stimulat

Prophylactic granulocyte colony-stimulating factor in patients receiving dose-intensive cancer chemotherapy: a meta-analysis

✍ Gary H Lyman; Nicole M Kuderer; Benjamin Djulbegovic 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 104 KB

Granulocyte colony stimulating factor (G

Granulocyte colony stimulating factor (G-CSF) enables dose intensification of chemotherapy in small cell lung cancer (SCLC)

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Preparation of immunotoxin using granulo

Preparation of immunotoxin using granulocyte colony-stimulating factor (G-CSF), for cancer therapy

✍ Soudabe Niknia; Parinaz Ghadam; Khosro Khaje; Mehdi Zeinoddini 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 109 KB

Pharmacokinetics of intravenous recombin

Pharmacokinetics of intravenous recombinant human granulocyte colony-stimulating factor (rhG-CSF) in children receiving myelosuppressive cancer chemotherapy: Clearance increases in relation to absolute neutrophil count with repeated dosing

✍ Sturgill, Marc G.; Huhn, Richard D.; Drachtman, Richard A.; Ettinger, Alice G.; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 2 views

Limited evidence suggests increased efficacy of rhG-CSF by subcutaneous (SQ) compared with intravenous (IV) administration. To examine the possibility that rapid elimination of IV rhG-CSF could substantially shorten the duration of systemic exposure and could explain a difference in pharmacodynamics